Tarsus Pharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Tarsus Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2018 to Q4 2023.
  • Tarsus Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $3.93M, a 15.8% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $3.93M +$535K +15.8% Dec 31, 2023 10-K 2024-02-27
Q4 2022 $3.39M +$348K +11.4% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $3.05M +$2.56M +524% Dec 31, 2021 10-K 2024-02-27
Q4 2020 $488K +$455K +1379% Dec 31, 2020 10-K 2023-03-17
Q4 2019 $33K +$13K +65% Dec 31, 2019 10-K 2022-03-14
Q4 2018 $20K Dec 31, 2018 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.